Unique skin manifestations of COVID-19: Is drug eruption specific to COVID-19?
•COVID-19 is associated with specific skin manifestations and drug eruption.•This case shows COVID-19–related drug eruption and specific clinical features.•Drug eruption preceding COVID-19 symptoms may facilitate early diagnosis.
Gespeichert in:
| Veröffentlicht in: | Journal of dermatological science 2020-07, Vol.99 (1), p.62-64 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 64 |
|---|---|
| container_issue | 1 |
| container_start_page | 62 |
| container_title | Journal of dermatological science |
| container_volume | 99 |
| creator | Sakaida, Takashi Tanimoto, Isao Matsubara, Akihiro Nakamura, Motoki Morita, Akimichi |
| description | •COVID-19 is associated with specific skin manifestations and drug eruption.•This case shows COVID-19–related drug eruption and specific clinical features.•Drug eruption preceding COVID-19 symptoms may facilitate early diagnosis. |
| doi_str_mv | 10.1016/j.jdermsci.2020.05.002 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7229941</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923181120301687</els_id><sourcerecordid>S0923181120301687</sourcerecordid><originalsourceid>FETCH-LOGICAL-c528t-99694a64259cdfd41aaaf2ab43504cb531212b964743d3e19c5225bba76901b43</originalsourceid><addsrcrecordid>eNqFkMlOwzAQhi0EoqXwCpVfIMFrUnNgUdkqIXqhiJvlOE5xaBbspBJvj6vSCk6c5vAvM_MBMMYoxggn52Vc5sZVXtuYIIJixGOEyAEY4klKI56It0MwRILQCE8wHoAT70uEECdMHIMBJYxwypMheF7U9rM30H_YGlaqtoXxnepsU3vYFHA6f53dRlhcwJmHueuX0Li-3cjQt0bbwmrYNXvb1Sk4KtTKm7OfOQKL-7uX6WP0NH-YTW-eIs3JpIuESARTSThC6LzIGVZKFURljHLEdMYpJphkImEpozk1WIQY4Vmm0kQgHGwjcLntbfusMrk2defUSrbOVsp9yUZZ-Vep7btcNmuZEiIEw6Eg2RZo13jvTLHPYiQ3hGUpd4TlhrBEXAbCITj-vXkf2yENhuutwYT_19Y4GSpMrU1undGdzBv7345v7RiPdw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Unique skin manifestations of COVID-19: Is drug eruption specific to COVID-19?</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>Sakaida, Takashi ; Tanimoto, Isao ; Matsubara, Akihiro ; Nakamura, Motoki ; Morita, Akimichi</creator><creatorcontrib>Sakaida, Takashi ; Tanimoto, Isao ; Matsubara, Akihiro ; Nakamura, Motoki ; Morita, Akimichi</creatorcontrib><description>•COVID-19 is associated with specific skin manifestations and drug eruption.•This case shows COVID-19–related drug eruption and specific clinical features.•Drug eruption preceding COVID-19 symptoms may facilitate early diagnosis.</description><identifier>ISSN: 0923-1811</identifier><identifier>EISSN: 1873-569X</identifier><identifier>DOI: 10.1016/j.jdermsci.2020.05.002</identifier><identifier>PMID: 32425356</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Anti-Inflammatory Agents, Non-Steroidal - adverse effects ; Betacoronavirus ; Cephalosporins - adverse effects ; Coronavirus Infections - complications ; COVID-19 ; Drug Eruptions - virology ; Female ; Humans ; Middle Aged ; Pandemics ; Phenylpropionates - adverse effects ; Pneumonia, Viral - complications ; SARS-CoV-2</subject><ispartof>Journal of dermatological science, 2020-07, Vol.99 (1), p.62-64</ispartof><rights>2020 The Authors</rights><rights>2020 The Authors 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c528t-99694a64259cdfd41aaaf2ab43504cb531212b964743d3e19c5225bba76901b43</citedby><cites>FETCH-LOGICAL-c528t-99694a64259cdfd41aaaf2ab43504cb531212b964743d3e19c5225bba76901b43</cites><orcidid>0000-0001-8372-3754 ; 0000-0003-4431-7782</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jdermsci.2020.05.002$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,3549,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32425356$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sakaida, Takashi</creatorcontrib><creatorcontrib>Tanimoto, Isao</creatorcontrib><creatorcontrib>Matsubara, Akihiro</creatorcontrib><creatorcontrib>Nakamura, Motoki</creatorcontrib><creatorcontrib>Morita, Akimichi</creatorcontrib><title>Unique skin manifestations of COVID-19: Is drug eruption specific to COVID-19?</title><title>Journal of dermatological science</title><addtitle>J Dermatol Sci</addtitle><description>•COVID-19 is associated with specific skin manifestations and drug eruption.•This case shows COVID-19–related drug eruption and specific clinical features.•Drug eruption preceding COVID-19 symptoms may facilitate early diagnosis.</description><subject>Anti-Inflammatory Agents, Non-Steroidal - adverse effects</subject><subject>Betacoronavirus</subject><subject>Cephalosporins - adverse effects</subject><subject>Coronavirus Infections - complications</subject><subject>COVID-19</subject><subject>Drug Eruptions - virology</subject><subject>Female</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>Pandemics</subject><subject>Phenylpropionates - adverse effects</subject><subject>Pneumonia, Viral - complications</subject><subject>SARS-CoV-2</subject><issn>0923-1811</issn><issn>1873-569X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMlOwzAQhi0EoqXwCpVfIMFrUnNgUdkqIXqhiJvlOE5xaBbspBJvj6vSCk6c5vAvM_MBMMYoxggn52Vc5sZVXtuYIIJixGOEyAEY4klKI56It0MwRILQCE8wHoAT70uEECdMHIMBJYxwypMheF7U9rM30H_YGlaqtoXxnepsU3vYFHA6f53dRlhcwJmHueuX0Li-3cjQt0bbwmrYNXvb1Sk4KtTKm7OfOQKL-7uX6WP0NH-YTW-eIs3JpIuESARTSThC6LzIGVZKFURljHLEdMYpJphkImEpozk1WIQY4Vmm0kQgHGwjcLntbfusMrk2defUSrbOVsp9yUZZ-Vep7btcNmuZEiIEw6Eg2RZo13jvTLHPYiQ3hGUpd4TlhrBEXAbCITj-vXkf2yENhuutwYT_19Y4GSpMrU1undGdzBv7345v7RiPdw</recordid><startdate>20200701</startdate><enddate>20200701</enddate><creator>Sakaida, Takashi</creator><creator>Tanimoto, Isao</creator><creator>Matsubara, Akihiro</creator><creator>Nakamura, Motoki</creator><creator>Morita, Akimichi</creator><general>Elsevier B.V</general><general>The Authors. Published by Elsevier B.V. on behalf of Japanese Society for Investigative Dermatology</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-8372-3754</orcidid><orcidid>https://orcid.org/0000-0003-4431-7782</orcidid></search><sort><creationdate>20200701</creationdate><title>Unique skin manifestations of COVID-19: Is drug eruption specific to COVID-19?</title><author>Sakaida, Takashi ; Tanimoto, Isao ; Matsubara, Akihiro ; Nakamura, Motoki ; Morita, Akimichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c528t-99694a64259cdfd41aaaf2ab43504cb531212b964743d3e19c5225bba76901b43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Anti-Inflammatory Agents, Non-Steroidal - adverse effects</topic><topic>Betacoronavirus</topic><topic>Cephalosporins - adverse effects</topic><topic>Coronavirus Infections - complications</topic><topic>COVID-19</topic><topic>Drug Eruptions - virology</topic><topic>Female</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>Pandemics</topic><topic>Phenylpropionates - adverse effects</topic><topic>Pneumonia, Viral - complications</topic><topic>SARS-CoV-2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sakaida, Takashi</creatorcontrib><creatorcontrib>Tanimoto, Isao</creatorcontrib><creatorcontrib>Matsubara, Akihiro</creatorcontrib><creatorcontrib>Nakamura, Motoki</creatorcontrib><creatorcontrib>Morita, Akimichi</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of dermatological science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sakaida, Takashi</au><au>Tanimoto, Isao</au><au>Matsubara, Akihiro</au><au>Nakamura, Motoki</au><au>Morita, Akimichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Unique skin manifestations of COVID-19: Is drug eruption specific to COVID-19?</atitle><jtitle>Journal of dermatological science</jtitle><addtitle>J Dermatol Sci</addtitle><date>2020-07-01</date><risdate>2020</risdate><volume>99</volume><issue>1</issue><spage>62</spage><epage>64</epage><pages>62-64</pages><issn>0923-1811</issn><eissn>1873-569X</eissn><abstract>•COVID-19 is associated with specific skin manifestations and drug eruption.•This case shows COVID-19–related drug eruption and specific clinical features.•Drug eruption preceding COVID-19 symptoms may facilitate early diagnosis.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>32425356</pmid><doi>10.1016/j.jdermsci.2020.05.002</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0001-8372-3754</orcidid><orcidid>https://orcid.org/0000-0003-4431-7782</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-1811 |
| ispartof | Journal of dermatological science, 2020-07, Vol.99 (1), p.62-64 |
| issn | 0923-1811 1873-569X |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7229941 |
| source | Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE |
| subjects | Anti-Inflammatory Agents, Non-Steroidal - adverse effects Betacoronavirus Cephalosporins - adverse effects Coronavirus Infections - complications COVID-19 Drug Eruptions - virology Female Humans Middle Aged Pandemics Phenylpropionates - adverse effects Pneumonia, Viral - complications SARS-CoV-2 |
| title | Unique skin manifestations of COVID-19: Is drug eruption specific to COVID-19? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T11%3A14%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Unique%20skin%20manifestations%20of%20COVID-19:%20Is%20drug%20eruption%20specific%20to%20COVID-19?&rft.jtitle=Journal%20of%20dermatological%20science&rft.au=Sakaida,%20Takashi&rft.date=2020-07-01&rft.volume=99&rft.issue=1&rft.spage=62&rft.epage=64&rft.pages=62-64&rft.issn=0923-1811&rft.eissn=1873-569X&rft_id=info:doi/10.1016/j.jdermsci.2020.05.002&rft_dat=%3Celsevier_pubme%3ES0923181120301687%3C/elsevier_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32425356&rft_els_id=S0923181120301687&rfr_iscdi=true |